Director David LaPre resigns from Calidi Biotherapeutics board

Calidi Biotherapeutics, Inc.

David LaPre resigned as director and from all board committees effective May 10, 2024.
Resignation not due to any dispute with the company or Board on operations or policies.
No replacement director has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David LaPre

Director

CLDI · Calidi Biotherapeutics, Inc.

Effective: 2024-05-10
Filed: May 16, 2024, 7:59 PM ET

On May 10, 2024, Mr. David LaPre notified the Board of Directors (the “Board”) of Calidi Biotherapeutics, Inc. (the “Company”) of his resignation as a director of the Company, including his position on each Board committee on which he served, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David LaPre resigned as Director at Calidi Biotherapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On May 10, 2024, Mr. David LaPre notified the Board of Directors (the “Board”) of Calidi Biotherapeutics, Inc. (the “Company”) of his resignation as a director of the Company, including his position on each Board committee on which he served, effective immediately.

View on SEC.gov

Calidi Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-020222

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.